Friedemann R. Borner
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
H3.1 Nucleosomes to Predict Renal Replacement Therapy and Mortality in Sepsis-A Secondary Analysis of the SISPCT Randomized Control Trial.
Journal: Critical care medicine
Published: August 03, 2026
Circulating alpha-1 antitrypsin and its c-terminal peptides differentiate bacterial from viral community-acquired pneumonia.
Journal: Journal of translational medicine
Published: June 04, 2026
Quantitative analysis of murine C-terminal alpha-1-antitrypsin peptides in experimental sepsis and their comparison with human sepsis peptide biomarkers.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: June 01, 2026
Protein Fragments: From Biomarkers to Therapeutic Targets-A Focus on α1-Antitrypsin-Derived Peptides.
Journal: Mediators of inflammation
Published: February 11, 2026
Circulating C-terminal peptides and polymers of alpha-1 antitrypsin as putative markers of pediatric Pi*ZZ liver disease.
Journal: Frontiers in pediatrics
Published: October 01, 2025
Bioactive peptides in therapeutic α1-Antitrypsin preparations modulate neutrophil chemokine receptors: Implications for augmentation therapy.
Journal: Respiratory medicine and research
Published: September 18, 2025
Boswellia serrata extract with low 3O-acetyl-11-keto-β-boswellic acid-content causes efficient lipid mediator class switch.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 15, 2025
Serum levels of C-terminal peptides of alpha-1 antitrypsin as potential biomarkers in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: February 18, 2025
Alpha-1-antitrypsin as novel substrate for S. aureus' Spl proteases - implications for virulence.
Journal: Frontiers in immunology
Published: August 15, 2024
Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells.
Journal: Frontiers in pharmacology
Published: November 03, 2023
Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 21, 2023
Last Updated: 09/26/2026